Compare PIPR & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PIPR | IRTC |
|---|---|---|
| Founded | 1895 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 4.8B |
| IPO Year | 2003 | 2016 |
| Metric | PIPR | IRTC |
|---|---|---|
| Price | $279.66 | $114.41 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 13 |
| Target Price | ★ $362.50 | $207.54 |
| AVG Volume (30 Days) | 178.4K | ★ 621.5K |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | ★ 2.69% | N/A |
| EPS Growth | 54.49 | ★ 61.71 |
| EPS | ★ 15.82 | N/A |
| Revenue | ★ $1,904,217,000.00 | $747,138,000.00 |
| Revenue This Year | $13.09 | $19.58 |
| Revenue Next Year | $14.76 | $15.95 |
| P/E Ratio | $18.32 | ★ N/A |
| Revenue Growth | 24.33 | ★ 26.24 |
| 52 Week Low | $202.91 | $92.52 |
| 52 Week High | $380.26 | $210.01 |
| Indicator | PIPR | IRTC |
|---|---|---|
| Relative Strength Index (RSI) | 30.86 | 26.14 |
| Support Level | $248.90 | N/A |
| Resistance Level | $341.25 | $161.36 |
| Average True Range (ATR) | 11.28 | 6.23 |
| MACD | -1.47 | -1.19 |
| Stochastic Oscillator | 5.66 | 4.31 |
Piper Sandler Cos is an investment bank and institutional securities firm, serving the needs of corporations, private equity groups, public entities, non-profit entities and institutional investors in the United States (U.S.) and internationally. The company provides a broad set of products and services, including financial advisory services; equity and debt capital markets products; public finance services; institutional brokerage services; fundamental equity and macro research services; fixed income services; and alternative asset management strategies. It generates maximum revenue from Advisory services followed by Equity financing.
iRhythm Holdings Inc formerly, iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.